News

Illustration depicting translational kidney cancer research. A transparent kidney containing a tumor is shown beside a molecular target labeled HIF-2α, representing the biological pathway driving disease. Scientific imagery including DNA strands, laboratory equipment, molecular structures, a microscope, and a test tube suggests biomedical research and precision oncology. Graphical elements illustrate clinical outcomes, including tumor response and disease control metrics, conveying the relationship between targeted therapy, biomarker science, and patient outcomes in kidney cancer research. Inspired by research evaluating HIF-2α inhibition as a treatment strategy for advanced clear cell renal cell carcinoma.

Sylvester Comprehensive Cancer Center Study Signals Novel Option for Hard-to-Treat Kidney Cancer

A Sylvester Comprehensive Cancer Center study reports durable responses from casdatifan, a novel HIF-2α inhibitor, in patients with advanced kidney cancer.

Jul. 02 2026 |
Dr. Brooke Crawford sits at a laboratory workstation beside a microscope and research equipment, wearing a white UHealth lab coat and smiling toward the camera.

Miller School of Medicine Orthopaedic Oncology Chief Dr. Brooke Crawford on AI, Fracture Prediction and Mentoring Future Surgeons

Brooke Crawford, M.D., shares how AI could improve fracture prediction in bone cancer patients and discusses research and resident mentoring.

Jul. 01 2026 |
Ansh Bhatt speaks at a podium during the Rice Business Plan Competition, with Ion District branding and sponsor logos displayed behind him.

How Running a Startup Shapes Ansh Bhatt’s Medical Training at the University of Miami Miller School of Medicine

Miami M.D./M.B.A. student Ansh Bhatt balances medical school at the Miller School with leading the startup ChargeBay.

Jun. 30 2026 |
Students seated in a classroom listen as a speaker addresses the group during the M.D./M.P.H. Class of 2030 orientation at the University of Miami Miller School of Medicine.

University of Miami Miller School of Medicine Welcomes M.D./M.P.H. Class of 2030

The University of Miami Miller School of Medicine’s Class of 2030 M.D./M.P.H. cohort is the largest in the nation.

Jun. 30 2026 |

Videos

Social Media